Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...
Using switches is one of the cleanest ways to compare different listing venues. The results still show that stocks trade better when they’re listed on Nasdaq. That’s true in the open auction, during ...
Analysts at StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the stock. NantHealth Stock Up ...
Results that may be inaccessible to you are currently showing.